(Q51666888)

English

Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment.

scientific article published on 25 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

Barbara S van der Meij

1

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

Annemieke C Heijboer

6

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

author name string

Jacqueline A E Langius

2

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

Egbert F Smit

3

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

Marieke D Spreeuwenberg

4

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

B Mary E von Blomberg

5

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

Marinus A Paul

7

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

Paul A M van Leeuwen

8

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

language of work or name

0 references

publication date

25 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

Journal of Nutrition

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

140

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

10

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

1774-1780

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Chemoradiation for unresectable stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Cachexia: a new definition

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Cytokines and cancer anorexia cachexia syndrome

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Immunomodulation by omega-3 fatty acids.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Role of omega-3 fatty acid supplementation in inflammation and malignancy

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Fatty fish-induced changes in membrane lipid composition and viscosity of human erythrocyte suspensions

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

New methods for calculating metabolic rate with special reference to protein metabolism

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Validation of predictive equations for resting energy expenditure in adult outpatients and inpatients.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

The rational clinical examination. Is this patient malnourished?

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Screening of nutritional status in The Netherlands

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Single prediction equation for bioelectrical impedance analysis in adults aged 20--94 years.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Relation between the longitudinal development of lipoprotein levels and lifestyle parameters during adolescence and young adulthood.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease—A randomized controlled trial

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Does nutrition influence quality of life in cancer patients undergoing radiotherapy?

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Marine phospholipids--a promising new dietary approach to tumor-associated weight loss.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

The effects of immediate enteral feeding with a formula containing high levels of omega-3 fatty acids in patients after surgery for esophageal cancer

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.

1 reference

https://api.crossref.org/works/10.3945%2FJN.110.121202

21 January 2018

Identifiers

10.3945/JN.110.121202

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/20739445

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51666888&oldid=1120451942"